Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cholera/enterotoxigenic Escherichia coli vaccine - Celldex Therapeutics Inc

Next Previous
X
Search
Drug Profile

Cholera/enterotoxigenic Escherichia coli vaccine - Celldex Therapeutics Inc

Alternative Names: Cholera/ETEC vaccine; Combined ETEC-cholera vaccine [Peru-15-pCTB (Cholera toxin B-subunit)] - Celldex/NIAID; Combined live, attenuated, enterotoxigenic Escherichia coli (ETEC)-cholera Vaccine (Peru-15 pCTB) - Celldex Therapeutics/NIAID; ETEC/cholera vaccine; Peru-15 pCTB; Traveller's diarrhoea vaccine - Celldex Therapeutics

Latest Information Update: 04 Nov 2017

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Celldex Therapeutics Inc
  • Developer Celldex Therapeutics Inc; National Institute of Allergy and Infectious Diseases
  • Class Bacterial vaccines; Cholera vaccines; Escherichia coli vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Cholera; Escherichia coli infections

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for phase-I development in Cholera(Prevention, In volunteers) in USA (PO)
  • 04 Nov 2017 No recent reports of development identified for phase-I development in Escherichia-coli-infections(Prevention, In volunteers) in USA (PO)
  • 03 Feb 2011 NIAID completes a Phase-I clinical trial in the prevention of Escherichia coli infections and cholera (in volunteers) in USA (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top